The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126396471 12639647 1 I 20140304 20160803 20160810 20160810 EXP FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064240 BRISTOL MYERS SQUIBB 55.15 YR F Y 56.00000 KG 20160810 MD FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126396471 12639647 1 PS ENTECAVIR. ENTECAVIR 1 Unknown 0.5 MG, QD 21797 .5 MG FILM-COATED TABLET QD
126396471 12639647 2 SS VIREAD TENOFOVIR DISOPROXIL FUMARATE 1 Unknown 245 MG, EVERY 3 DAYS 0 245 MG TABLET
126396471 12639647 3 C KARDEGIC ASPIRIN LYSINE 1 Unknown 75 MG, QD 0 75 MG QD
126396471 12639647 4 C ESOMEPRAZOLE ESOMEPRAZOLE 1 Unknown 20 MG, QD 0 20 MG QD
126396471 12639647 5 C GAVISCON /00237601/ ALUMINUM HYDROXIDEMAGNESIUM CARBONATE 1 Unknown 1 DF, QD 0 1 DF QD
126396471 12639647 6 C ZOPHREN /00955301/ ONDANSETRON 1 Unknown 2 TAB, QD 0 2 DF QD
126396471 12639647 7 C BISOPROLOL BISOPROLOL 1 Unknown 1.25 MG, QD 0 1.25 MG QD
126396471 12639647 8 C VALSARTAN. VALSARTAN 1 Unknown 1 DF, 80/125MG 0 1 DF QD
126396471 12639647 9 C AMLODIPINE AMLODIPINE BESYLATE 1 Unknown 5 MG, BID 0 5 MG BID
126396471 12639647 10 C GABAPENTINE GABAPENTIN 1 Unknown 300 MG, BID 0 300 MG BID
126396471 12639647 11 C ACTISKENAN MORPHINE SULFATE 1 Unknown 10 MG, MAXIMUM OF 6/D 0 10 MG
126396471 12639647 12 C MOVICOL POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE 1 Unknown UNK UNK, QD U 0 QD
126396471 12639647 13 C NORMACOL KARAYA GUM 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126396471 12639647 1 Hepatitis B
126396471 12639647 2 Hepatitis B
126396471 12639647 3 Ischaemic cardiomyopathy
126396471 12639647 4 Hiatus hernia
126396471 12639647 5 Hiatus hernia
126396471 12639647 6 Nausea
126396471 12639647 7 Cardiac disorder
126396471 12639647 8 Hypertension
126396471 12639647 9 Hypertension
126396471 12639647 10 Back pain
126396471 12639647 11 Back pain
126396471 12639647 12 Product used for unknown indication
126396471 12639647 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126396471 12639647 OT
126396471 12639647 HO
126396471 12639647 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
126396471 12639647 Chronic kidney disease
126396471 12639647 Hepatocellular carcinoma
126396471 12639647 Metastases to spine
126396471 12639647 Packed red blood cell transfusion
126396471 12639647 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126396471 12639647 1 200703 0
126396471 12639647 2 2012 0
126396471 12639647 4 2009 0
126396471 12639647 6 2014 0
126396471 12639647 11 2014 0